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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
1. To compare the effects (see outcomes below) of different total* doses (in terms of boluses, concentration, volume and timeframe)
of opioid epidural (excluding combined-spinal epidural and intrathecal) analgesia administered (alone or as adjunctive) during labour
on the woman and the infant.
2. To compare the safety (see outcomes below) of different total* doses (as above) of opioid epidural analgesia administered during
labour for the woman and the infant.
*We define ‘total’ as the sum of all boluses and infusions (concentration, volume and timeframe) administered between onset of labour
(as defined by authors) and delivery. If analgesia post-delivery is reported, we shall describe this separately.
We shall undertake secondary analyses of drug concentrations and volumes, see Types of interventions. However, since opioids pass
into the fetus, and may accumulate, total dose is an important consideration for infant adverse events, such as drowsiness. (see Why it
is important to do this review).
B A C K G R O U N D
Description of the condition
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Pain in labour
The pain experienced in labour is affected by multiple physio-
logical and psychosocial factors (Jones 2012). Perceptions of pain
intensity vary. Occasionally women feel no pain in labour. At the
other extreme, labour pain has been reported to be themost severe
pain that a woman experiences in her lifetime (Melzack 1984).
Physiology
Pain originates from different sites during labour and birth. In the
first stage of labour (defined as the period from the onset of labour
to the complete dilatation of the cervix) (NLM 1991), pain occurs
during contractions, is visceral or cramp-like in nature, originates
in the uterus and cervix, and is produced by distension of uterine
tissues and dilation of the cervix. In the first stage, pain is transmit-
ted via spinal nerves T10-L1. Labour pain can be referred to the
abdominal wall, lumbosacral region, iliac crests, gluteal areas, and
thighs. The transition phase of labour refers to the shift from the
late first stage (7 cm to 10 cm cervical dilation) to the second stage
of labour (full dilation). In the second stage of labour (defined as
from full cervical dilation to the delivery of the baby) (Marcovitch
2010), pain occurs from distension of the vagina, perineum, and
pelvic floor. In the second stage, pain is transmitted via the puden-
dal nerves, entering the spinal cord via nerve roots S2-S4. Stretch-
ing of the pelvic ligaments is the hallmark of the second stage of
labour. Second stage pain is characterised by a combination of vis-
ceral pain from uterine contractions and cervical stretching and
somatic pain from distension of vaginal and perineal tissues (Jones
2012).
Factors affecting pain in labour
Many factors influence the physiological and psychological pro-
cesses of birth and the extent to which women experience pain,
including parity, induction of labour and the way labour is man-
aged. The pattern of pain appears to differ between nulliparous
andmultiparouswomen.Typically, nulliparouswomen experience
greater sensory pain than multiparous women during early labour
(before 5 cmdilatation) (Lowe 2002).Womenmay also experience
induced labour as being more painful than spontaneous labour
(NCC 2008). The perception of pain and administration of anal-
gesia during childbirth is also influenced by provision of contin-
uous intrapartum support, continuity of care or midwife-led care
(Begley 2009; Hodnett 2013; Sandall 2013; Skibsted 1992).
Description of the intervention
Most labouring women require pain relief. Many non-pharmaco-
logical methods are helpful, but are often insufficient. The need
for effective analgesia in labour has led to widespread adoption
of regional or neuraxial analgesia, which may be administered by
one of three techniques: epidural, intrathecal, and the combined
spinal-epidural approach. Of these, the epidural route is the most
established (NCC 2007).
Epidurals
Epidural analgesia is widely used during labour. Data from the
National (UK) Obstetric Anaesthesia Database (NOAD) for
2011 (most recent data available) indicate that 22.7% (126,749/
558,256) of women in labour used regional analgesia; this pro-
portion has remained largely unchanged since 2008. In over
91% of these 126,749 women, analgesia was initiated epidurally,
with other methods, such as combined spinal epidural anaes-
thetics, accounting for the remainder (NOAD 2013). Hospital
Episode Statistics 2013 for England 2011/12 suggest similar fig-
ures: 99,379 of 668,936 (17.1%) women giving birth received
epidural or caudal analgesia without intrathecal analgesia. Use is
higher inNorth America, with 61%of 1,829,302womenwhohad
a singleton birth in a vaginal delivery in 27 states of the USA and
Canada in 2008 receiving epidural or spinal anaesthesia (Osterman
2011). Despite widespread adoption of epidural analgesia, succes-
sive UK guidelines for intrapartum care highlighted the paucity of
the evidence base for optimising epidural regimens (NCC 2007,
NCC 2014). Dose optimisation involves evaluating the balance
of benefits and harms for the whole dyad, during labour and in
the longer term, based on research evidence and shared decision-
making between women and healthcare professionals.
Epidural administration involves the injection of drugs, usually
both a local anaesthetic and an opioid, into the epidural space in
the lower region of the spine, close to the nerves that transmit
painful stimuli from the contracting uterus and the birth canal
(Jones 2012). The drugs act locally, but also pass into the circula-
tion and cross the placenta (Jordan 2010). The most commonly
prescribed local anaesthetic is bupivacaine; levobupivacaine, ropi-
vacaine, and lidocaine/lignocaine are also used in epidural injec-
tions (Hillyard 2011). The most commonly prescribed opioid is
fentanyl (NCC 2014), but other opioids are used, including mor-
phine, diamorphine, and sufentanil. This review focuses on opi-
oids.
How the intervention might work
The term ‘opioid’ describes any preparation acting on the body’s
opioid receptors, for example morphine, diamorphine, fentanyl,
and alfentanil. Opioids are chemically related to the body’s en-
dorphins and enkephalins, which are natural mood changers and
analgesics, particularly in times of pain and stress (Jordan 2010;
Vuong 2010).
Opioids act on specific receptors in the central nervous system
and throughout the body. This triggers changes within nerve or
smooth muscle cells, usually inhibiting their activity and neuro-
transmitter release. In general, opioids (endogenous and pharma-
cological) depress the activity of target tissues and have a calming
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effect. Opioids attenuate a) the stress response by reducing the
activity of the sympathetic nervous system and ACTH secretion
(Drolet 2001; Vuong 2010), and b) pain by stimulating opioid
receptors in the dorsal horn of the spinal cord, the brain stem
(both the reticular activating system and the periaqueductal grey
matter), and parts of the frontal cortex (Melzack 1965; Wagner
2007). They also reduce pain transmission in peripheral tissues,
particularly where inflammation is present (Carr 1999).
The literature offers no definitions of high and lowdoses for epidu-
ral opioids, and several doses have been compared (see Types of
interventions). The report from a six-arm trial of different dose
combinations (fentanyl and ropivacaine) administered in labour,
in which there was no follow through by the investigators to the
birth, suggested that analgesia using fentanyl plus ropivacaine is
determined by themass of drug administered, rather than concen-
tration or volume (Bernard 2003). In contrast, work on epidural
local anaesthetics suggests that analgesia depends on both volume
and mass of drug administered, and larger volumes are better able
to cover the drug target sites (the nerve roots in the epidural space)
(Christiaens 1998; Lyons 2007). However, opioids act on more
closely defined targets, receptors on cell bodies in the dorsal horn
of the spinal cord (Eltzschig 2003), and may be less reliant on
diffusion within the epidural space.
Why it is important to do this review
Consumers identified pain relief in labour as the topic of most im-
portance to them (Jones 2012). However, the overview of system-
atic reviews of painmanagement in labour identified no systematic
reviews comparing epidural opioid regimens. The only existing
systematic review of regimens included in the overview compares
bupivacaine with ropivacaine (Halpern 2003). Low concentra-
tions of bupivacaine and fentanyl are recommended for epidural
administration (NCC 2014). There is a consensus on the need to
use lower concentrations of local anaesthetics (NCC 2014), due,
in part, to associations with increased rates of instrumental deliv-
ery and difficulty in mobilisation during labour (COMET 2001).
However, there is more uncertainty and variation surrounding the
appropriate dose of epidural opioids. Although only small quan-
tities of drug reach the maternal and fetal circulations following
epidural administration (Eltzschig 2003), there are some concerns
about the adverse effects of opioids (Jones 2012; Jordan 2005).
Possible maternal adverse effects include: sedation, hypoventila-
tion, hypotension, prolonged labour, urine retention, itching, nau-
sea and/or vomiting, and the slowing of gastric emptying (Jordan
2010). Sedation was less common in women receiving lower doses
of sufentanil in combined spinal epidural regimens in a small trial
(n = 42) (Sia 1999). If a woman feels drowsy or sedated, she is less
likely to mobilise and adopt an upright position and, as a result,
this may lengthen her labour and make it more painful (Lawrence
2009).
Opioids readily cross the placenta by passive diffusion: the con-
centration of fentanyl in the umbilical artery is 89% to 94% of
that of maternal venous plasma (Bader 1995; Moises 2005). Fen-
tanyl accumulates in the placental intervillous space (de barros
Duarte 2009) and the fetus (Desprats 1991; Lofuts 1995), and is
released from binding proteins (albumins) in the first few hours
of neonatal life (Porter 1998). Therefore, the total dose that may
be sequestered in placental or fetal tissues merits consideration
(Jordan 2005). The fetus has a higher concentration of free or
unbound opioids than the mother, and this increases if the fetus
becomes acidotic (Helbo-Hansen 1995), for example, in events
leading up to emergency caesarean sections. Neonatal respiratory
depression and hypothermia are occasionally reported in associ-
ation with epidural opioids (Carrie 1981), particularly at higher
doses (Kumar 2003). Some trials and observational studies suggest
associations between epidural analgesia or higher doses of epidural
opioids and reduced suckling or breastfeeding rates (Beilin 2005;
Henderson 2003; Jordan 2005; Jordan 2009; Torvaldsen 2006).
Epidural solutions are administered by bolus or continuous infu-
sion or patient-controlled pump (NCC 2014). Boluses of higher
concentrations of local anaesthetics, as used in earlier years, have
been associated with a dense motor block resulting in reducedmo-
bility, decreased pelvic tone and impairment of the bearing down
effort in the second stage of labour (Thornton 2001). More re-
cently, there has been a trend to use a lower concentration of local
anaesthetic in combination with a variety of opioids; these combi-
nations provide analgesia while allowing the woman to maintain
somemotor function, including the ability tomove and bear down
during labour (COMET 2001; Russell 2000). As local anaesthetic
concentrations have been reduced, opioids have been increased
to ensure adequate analgesia, but the dose ranges employed have
not, as yet, been subject to the same scrutiny. The most pressing
uncertainties include the following.
Instrumental delivery rates
Previous Cochrane reviews have indicated that, when compared
with non-epidural analgesia, epidural analgesia increases the rate
of instrumental deliveries, while reducing pain during the second
stage (Anim-Somuah 2011). How these benefits and harms are
mitigated by alterations in dose is uncertain. For example, there
is evidence, from nulliparae, that instrumental deliveries are less
frequent with lower-dose local anaesthetic regimens (COMET
2001), while a trial of patient-controlled epidural analgesia, in
which the doses of fentanyl and ropivacaine were increased in
tandem, suggests that instrumental deliveries may be less frequent
when smaller, less frequent boluses are available (Lim 2008).
Oxytocin administration
Endogenous and epidural opioids decrease release of oxytocin from
the posterior pituitary and reduce contractility of uterine smooth
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muscle by direct action onmu2 /µ2 opioid receptors (Carter 2003;
Rahm 2002). Both intravenous opioids (Sosa 2006) and epidurals
(Anim-Somuah 2011), increase the need for oxytocin administra-
tion.Oxytocin administration is, in turn, associatedwith a range of
adverse effects, including excessive, and extremely painful, uterine
contractions (Bramadat 1994; Fraser 1998), escalating the need
for analgesia. Its extensive use in women labouring for the first
time is of concern (NCC 2007).
Caesarean rates
The impact of epidural analgesia on caesarean section rates merits
further analysis. Previous Cochrane reviews have indicated that,
when compared with non-epidural analgesia, epidural analgesia
increases the rate of caesareans for fetal distress, but not overall, and
without adversely affecting Apgar scores (Anim-Somuah 2011).
Trials suggest that the incidence of caesarean section is increased
if:
1. two or more rescue bolus doses of bupivacaine are
administered (Hess 2000);
2. epidural analgesia is administered prior to either cervical
dilatation greater than 5 cm (Thorp 1993) or engagement of the
fetal head (Traynor 2000), but more recent evidence does not
support this (NCC 2014);
3. oxytocin is administered as low dose, rather than high dose
(4 to 12 milliunits per minute), regimens (Kotaska 2006);
4. only sections for fetal distress are considered
(Anim-Somuah 2011).
These effects have been attributed to the local anaesthetics in the
regimens administered, but further investigation is needed.
Infant feeding and neonatal respiratory distress
There is uncertainty regarding the impact of epidural opioids
on breastfeeding rates. While some trials have shown an associa-
tion between higher doses of epidural fentanyl (Beilin 2005, see
Types of interventions) or any epidural fentanyl (Henderson 2003)
and feeding infant formula, others found that adding fentanyl to
unspecified quantities of bupivacaine (Wilson 2010, seeTypes of
interventions) and 50 mcg bolus plus infusions, compared with
no analgesia during labour (Radzyminski 2003) do not reduce
breastfeeding. Despite reassuring findings from a small trial of
epidural analgesia with and without fentanyl (n = 138) (Porter
1998), a case control study (n = 412) found an association be-
tween epidurals containing opioids and neonatal respiratory dis-
tress (Kumar 2014), and a meta-analysis suggested a higher risk
with sufentanil (Li 2015). Accordingly, obstetricians are advised
to avoid high doses of opioids before delivery ‘for the sake of the
infant’ (Reynolds 2010; Reynolds 2011).
Floor and ceiling effects
It is possible that different doses above or below certain thresholds
will not affect outcomes - the ceiling and floor effects. For example,
95% of women receiving a bolus dose of 50mcg fentanyl or 8mcg
sufentanil will be pain free for 100 to 180 minutes, based on the
empirically derivedED95 (Herman1998). ED95 (effective dose for
95%) is the amount of drug needed to achieve the desired effect,
or success, in 95% of those exposed. Women receiving 0 to 50
mcg fentanyl bolus experienced less satisfaction and pruritus than
those receiving higher doses, but there were minimal differences
in outcomes between the 75 and 100 mcg fentanyl groups (Bang
2012).
The transfer of drug into the fetus may vary at different doses.
Due to local binding in maternal tissues, the minimum dose to
affect the infant may be higher than that affecting the mother, but
more evidence is required (Reynolds 2011).
Epidural analgesia is effective (Anim-Somuah 2011). Reduction
in pain-induced physiological disturbance is likely to benefit both
the woman and the infant (Jordan 2010). Therefore, dose opti-
misation warrants full investigation. In this systematic review, we
compare high- and low-dose epidural regimens, aimed at relieving
pain and helping women cope with pain in labour (NCC 2014).
Total dose may be a useful marker to identify dyads at risk of ad-
verse events and target extra support (Jordan 2005; Jordan 2009).
The clinical relevance of the review will be increased by comparing
the concentrations of opioids in the epidural regimen.
O B J E C T I V E S
1. To compare the effects (see outcomes below) of different
total* doses (in terms of boluses, concentration, volume and
timeframe) of opioid epidural (excluding combined-spinal
epidural and intrathecal) analgesia administered (alone or as
adjunctive) during labour on the woman and the infant.
2. To compare the safety (see outcomes below) of different
total* doses (as above) of opioid epidural analgesia administered
during labour for the woman and the infant.
*We define ‘total’ as the sum of all boluses and infusions (con-
centration, volume and timeframe) administered between onset
of labour (as defined by authors) and delivery. If analgesia post-
delivery is reported, we shall describe this separately.
We shall undertake secondary analyses of drug concentrations and
volumes, see Types of interventions. However, since opioids pass
into the fetus, and may accumulate, total dose is an important
consideration for infant adverse events, such as drowsiness. (see
Why it is important to do this review).
M E T H O D S
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Criteria for considering studies for this review
Types of studies
Types of studies to be considered for review will be all parallel-
arm randomised controlled trials involving comparison of high
and low (but > 0) total doses of epidural opioids administered for
pain relief in labour.
We shall include: trials where women are randomised to different
doses of the same opioid; unpublished studies, where information
can be obtained; multi-arm trials where two or more of the arms
compare different doses of epidural opioids*; cluster-randomised
trials; unblinded trials. We shall include trials where neither pri-
mary nor secondary outcomes are available, and note that they did
not contribute data to the review. We shall not restrict by duration
of follow up after childbirth.
We shall exclude: trials where women are randomised to different
opioids; all quasi-randomised studies; trials where the interven-
tions of interest cannot be separated from co-interventions*; trials
reported only in abstract, as they will not include sufficient infor-
mation (below); trials not following parturients to delivery**. We
consider cross-over designs to be inappropriate for evaluation of
rapidly evolving situations, such as childbirth.
*Trials where doses of more than one medicine vary between arms.
If any trial arms keep the non-opioid dose constant, the study
will be included. If both the opioid and the second drug vary,
or there is no information on the dose administered, the study
will be excluded from the main analysis, as it will be difficult to
disentangle the relative contributions.
** Trials that investigate the use of different doses of pain relief,
but do not follow the woman through to the birth, will not enable
estimation of the total dose administered and therefore will not
allow for evaluation of safety outcomes for the mother or infant.
Types of participants
Pregnant women receiving epidural pain relief in labour, regardless
of parity and whether labour was spontaneous or induced. (We
shall exclude trials (or trial arms): involving women undergoing
elective caesareans, recruiting multiple births only, or involving
womenwith known intrauterinedeaths.) Any trials examining only
multiple births or only women with known intrauterine deaths
will be excluded from the analysis, and reported narratively; it does
not seem logical to combine these with trials of singletons.
Types of interventions
High doses versus low doses of opioid epidural analgesia. We shall
take two approaches to this.
1. ‘High’ and ‘low’ doses of the same opioid, as defined and
reported by authors. Information on drug dose will include total
dose, boluses, concentration, volume and timeframe. This will
be converted to total dose (drug mass) where possible. It may be
necessary to calculate doses from information given and to check
these with authors. Where drug concentrations differ, we shall
consider the volume administered in a secondary analysis. If any
total dose has been administered in different volumes, we shall
use this information in this secondary analysis. Some investigators
suggest that epidural local anaesthetics are more effective when
administered in higher volumes (Lyons 2007), and opioids may
act similarly.
2.Defineddoses for selected opioids. Fentanyl is themost widely
reported opioid. Since there is no single threshold available from
the literature, it would be appropriate to explore the data based on
a series of drug mass aliquots as cut points: 50 mcg, 100 mcg, 150
mcg, 200 mcg, 300 mcg, based on previous randomised studies
(that would not meet the criteria for inclusion in this review).
Retrospective analysis of the COMET trial (Wilson 2010) inves-
tigated 100 mcg, 200 mcg and 300 mcg total fentanyl doses across
three trial arms and non-randomised comparators. The Comet
trial was designed to investigate three different techniques for
administering local anaesthetics: epidural bolus only, combined
spinal epidural, and low-dose epidural infusion. Additional anal-
gesia, both fentanyl and local anaesthetic, were given on request
in all arms, but total local anaesthetic doses are not documented
(COMET 2001).
Differences in fentanyl’s analgesic efficacy were identified between
50mcg and 100 mcg, but not between 75mcg and 100mcg (Bang
2012; Siddik-Sayyid 2008). Neither of these reported on the total
dose of local anaesthetic administered in labour.
Beilin 2005 defined high- and low-dose fentanyl as drug mass
above and below 150 mcg, as total dose in labour. There is no
information on doses of local anaesthetic administered, and some
parturients in the zero dose arm received fentanyl.
To increase clinical relevance and improve interpretation, we shall
repeat this analysis:
• using different infusion concentrations, for example, 1, 2,
3, 4 mcg/mL of fentanyl, as a secondary analysis.
• including trials where doses of non-opioid analgesia differed
between arms or information on supplementary or rescue
analgesia is incomplete, as a secondary analysis.
These analyses will be interpreted cautiously; however, they will
inform clinicians of the effects of planning opioid analgesia at
different doses.
Where there is more than one arm with different doses of the same
opioid and a non-opioid arm, we shall include the non-opioid arm
in the descriptive analysis only, if appropriate.
Cochrane reviews already cover: Epidural versus combined spinal
epidural analgesia (Simmons 2012) and Epidural versus non-epidu-
ral or no analgesia in labour (Anim-Somuah 2011).
Types of outcome measures
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This list of outcomes was developed in collaboration with mem-
bers of the Pregnancy and Childbirth Group (PCG) consumers’
group - see ’History’ in (Jones 2012). Some additions have been
made, pertinent to this review. Should multiple testing be neces-
sary, statistical significance will be interpreted cautiously.
Primary outcomes
Effects of interventions
• Pain intensity and/or satisfaction with pain relief (as defined
by authors). Visual analogue scales are widely used.
Safety of interventions
Outcome affecting both mother and baby
• Breastfeeding exclusive* or full** or partial*** (time points
specified by authors)
• Method of delivery (unassisted vaginal birth, assisted
vaginal birth, caesarean section)
Adverse effects for mother
Based onAnim-Somuah 2011†. We shall report all adverse events,
including those identified in the literature.
• Nausea and/or vomiting
• Itching
• Drowsiness
• Respiratory depression requiring oxygen administration or
other intervention
• Urinary retention
• Maternal hypotension (as defined by authors)/
administration of ephedrine
• Headache
• Headache requiring blood patch
• Epidural failure
• Epidural re-siting
• Malposition (as defined by authors)
• Perineal trauma requiring suturing
• Fever
• Shivering/inability to hold infant
• Maternal blood loss (as reported by authors)
• Uterine rupture
• Venous thromboembolic events
• Postnatal depression (authors’ definition, treatment for
depression or self-reported)
• Long-term backache (as defined by trial authors)
• Other adverse effects or morbidity (e.g. catheterisation
during labour, surgical amniotomy, motor blockade, local
anaesthetic toxicity, impaired consciousness, meningitis,
intensive care unit admission, paralysis, maternal death)
Adverse effects for infant
Based on Anim-Somuah 2011)†.
• Acidosis as defined by cord blood arterial pH less than 7.15
• Apgar score less than seven at five minutes
• Naloxone administration
• Neonatal hypoglycaemia (less than or equal to 1.67 mmol/
L)
• Birth trauma (defined by authors)
• Meconium staining of liquor (as reported by authors)
• Admission to special care baby unit/neonatal intensive care
unit (as defined by authors)
• Other short-term problems (as defined by authors, e.g.
seizures)
• Long-term adverse outcomes of neonatal complications
(defined by authors)
• Poor infant outcomes at long-term follow-up (as defined by
authors e.g. disability, brachial plexus damage, seizures)
• Other adverse effects as reported by authors (e.g. fetal or
neonatal death)
*Exclusive breastfeeding is defined as no other intake, including
liquids, water and solids entering the infant’smouth (Bolling 2007;
Labbok 1990). However,WHO (WHO2008;WHO 2009) relax
this to allow ‘oral rehydration solution, drops or syrups consisting
of vitamins, minerals supplements or medicines’ (p.4, p.4, respec-
tively). We propose to use the latter definition.
**Full breastfeeding comprises exclusive breastfeeding (above) plus
‘almost exclusive’ breastfeeding. The latter includes infants receiv-
ing water or juice or ritualistic feeds infrequently, in addition to vi-
tamins or minerals, as long as the vast majority of feeds are breast-
feeds (Chantry 2006; Labbok 1990; WHO 2009). Administra-
tion of water is an important consideration for those assessing in-
fantile diarrhoea. Predominant breastfeeding is similar to ‘almost
exclusive’ above, in that only non-human milk and food-based
fluids are excluded (WHO 2008).
***Partial breastfeeding is any breastfeeding, even if extensively
supplemented by non-human milk or formula feeds (Bolling
2007). Some authors have subdivided this category into high,
medium and low (Labbok 1990). WHO 2008 prefer the term
‘complementary feeding’.
†Some of these outcomes are normally associated with the local
anaesthetic components of epidural analgesia. We have decided
to retain the existing list both to ensure comparability between
reviews and lest any reductions in opioid doses are associated with
increased local anaesthetic adverse effects.
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Secondary outcomes
• Sense of control in labour (as defined by authors)
• Satisfaction with childbirth experience (as defined by
authors)
• Additional analgesia/ anaesthesia administered (e.g. total
dose and concentration of local anaesthetic administered,
number of ‘top up’ doses administered)
• Numbers receiving uterotonics for augmentation of labour
• Length of first stage of labour
• Length of second stage of labour
• Time between randomisation and delivery
• Caesarean section for fetal distress
• Caesarean section for dystocia
• Complications of mode of delivery, e.g. damage to
perineum from instrumental delivery
• Cost (as defined by authors)
• Other outcomes, such as effect (positive or negative) on
mother/baby interaction, concentration of drugs in cord blood
Post-delivery and post-operative analgesia may impact on long-
term outcomes. All available information will be included and
authors contacted if necessary.
Search methods for identification of studies
The following methods section of this protocol is based on a stan-
dard template used by the Cochrane Pregnancy and Childbirth
Group.
Electronic searches
We will contact the Trials Search Co-ordinator to search the
Cochrane Pregnancy and Childbirth Group’s Trials Register.
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE;
3. weekly searches of Embase;
4. handsearches of 30 journals and the proceedings of major
conferences;
5. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE and
Embase, the list of handsearched journals and conference pro-
ceedings, and the list of journals reviewed via the current aware-
ness service can be found in the ‘Specialized Register’ section
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
In addition, we plan to search: PubMed (1946 to current); SCO-
PUS [Elsevier] (primarily 1960 to current); Web of Science
[Thomson Reuters] (Citation databases:1970 to present and Con-
ference Proceedings from1990 to present); theMaternity& Infant
Care Database [OVID] (1971 to current); and CINAHL [Ebsco]
(1982 to current). Search strategies to be used for each database
are given in Appendix 1.
We also plan to search clinical trials databases identified for
planned, ongoing or unpublished trials (van Enst 2012) (
ClinicalTrials.gov, ISRCTN Registry, WHO International Clini-
cal Trials Registry Platform (ICTRP), International Federation of
Pharmaceutical Manufacturers and Associations [IFPMA]). The
search terms we plan to use are given in Appendix 2.
Searching other resources
We shall undertake:
1. handsearches of reference lists of papers identified;
2. searches for full papers relating to abstracts identified.
We will not apply any language or date restrictions.
Data collection and analysis
Selection of studies
Two review authors (from Sue Jordan (SJ), Lucy de Lloyd (LdeL),
Fiona Murphy (FM), Amy Brown (AB)) will independently assess
for inclusion all the potential studies we identify as a result of
the search strategy. All titles and abstracts will be double checked.
Where we are uncertain, we shall send for the study. We will
resolve any disagreements and uncertainties through discussion or,
if required, we will consult the relevant clinical specialists on the
team.
Data extraction and management
We will design a form to extract data. For eligible studies, at least
two review authors will extract the data using the agreed form.We
will resolve discrepancies through discussion or, if required, we
will consult a third review author. We will enter data into Review
Manager software (RevMan 2014) and check for accuracy.
When information regarding any of the above is unclear, we will
attempt to contact authors of the original reports to provide further
details.
Assessment of risk of bias in included studies
Two review authors (from SJ, FM, AB, LdeL, at least one will
have experience of Cochrane reviews or clinical trials, SJ, FM) will
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independently assess risk of bias for each study using the criteria
outlined in the Cochrane Handbook for Systematic Reviews of Inter-
ventions (Higgins 2011). We will resolve any disagreements and
uncertainties by discussion or by involving a third assessor.
(1) Random sequence generation (checking for possible
selection bias)
We will describe for each included study the method used to gen-
erate the allocation sequence in sufficient detail to allow an assess-
ment of whether it should produce comparable groups.
We will assess the method as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias, for example, where information is
missing.
We do not plan to include quasi-randomised trials.
(2) Allocation concealment (checking for possible selection
bias)
We will describe for each included study the method used to con-
ceal allocation to interventions prior to assignment and will assess
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We will assess the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
We do not plan to include quasi-randomised trials.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
We will describe for each included study the methods used, if
any, to blind study participants and personnel from knowledge of
which intervention a participant received. We will consider that
studies are at low risk of bias if they were blinded, or if we judge
that the lack of blinding would be unlikely to affect results. (For
example, anaesthetists administering epidurals will be aware of the
doses, but if they take no further part in the trial, this is unlikely
to affect outcomes.) We will assess blinding for different outcomes
or classes of outcomes separately. Some outcomes, such as pain
scores and satisfaction, are subjective, and may be influenced by
blinding. Other outcomes, such as method of delivery, are less
vulnerable to subjective judgements.
We will assess the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel;
• low, high or unclear risk of bias for data analysts.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We will describe for each included study the methods used, if any,
to blind outcome assessors from knowledge of which interven-
tion a participant received. We will assess blinding separately for
different outcomes or classes of outcomes. For some outcomes,
blinding is unlikely to affect the results, for example, caesarean
section, forceps delivery. Subjective outcomes, such as pain scores
and satisfaction, are more likely to be influenced by blinding.
We will assess methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We will describe for each included study, and for each outcome
or class of outcomes, the completeness of data including attrition
and exclusions from the analysis. We will state whether attrition
and exclusions were reported and the numbers included in the
analysis at each stage (compared with the total randomised par-
ticipants), reasons for attrition or exclusion where reported, and
whether missing data were balanced across groups or were related
to outcomes. Where sufficient information is reported, or can be
supplied by the trial authors, we shall re-include missing data in
the analyses which we undertake.
We will assess methods as:
• low risk of bias (no or less than 20% missing outcome data
AND missing outcome data balanced across groups);
• high risk of bias (≥ 20% missing outcome data; numbers or
reasons for missing data imbalanced across groups; ‘as treated’
analysis done with substantial departure of intervention received
from that assigned at randomisation; denominators unclear or
not reported);
• unclear risk of bias.
Where trials report per protocol and intention-to-treat analyses, we
shall undertake sensitivity analyses.
We shall treat imputed or last observation carried forward data as
missing (Moore 2012).
(5) Selective reporting (checking for reporting bias)
We will describe for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We will assess the methods as:
• low risk of bias (where it is clear that all of the study’s pre-
specified outcomes [identified on trial registries] and all expected
outcomes of interest to the review have been reported);
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• high risk of bias (where not all the study’s pre-specified
outcomes have been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
We shall tabulate missing outcomes in each study. Reasons for
selective reporting will be included, if available. We will contact
trial authors for information, if appropriate.
(6) Other bias (checking for bias due to problems not
covered by (1) to (5) above)
We will describe for each included study any important concerns
we have about other possible sources of bias, for example:
• Imbalance between trial arms in analgesia before labour or
after delivery;
• Imbalance between trial arms in non-opioid analgesia
during labour.
We will assess whether each study was free of other problems that
could put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
We shall report length of time between consent and labour or
delivery and duration of follow-up in each study, as markers of
study quality.
(7) Overall risk of bias
We will make explicit judgements about whether studies are at
high risk of bias, according to the criteria given in the Handbook
(Higgins 2011). With reference to (1) to (6) above, we will assess
the likely magnitude and direction of the bias and whether we
consider it is likely to impact on the findings. We will explore the
impact of the level of bias through undertaking sensitivity analyses
- see Sensitivity analysis.
If significant differences between trial arms are found, we shall
calculate the number of patients needed in studies with a risk ratio
of one to change the number needed to treat (reciprocal of absolute
risk reduction) to include 0 in its 95% confidence intervals.
Assessing the quality of the body of evidence using
the GRADE approach
The quality of the evidence will be assessed using the GRADE
approach as outlined in the GRADE handbook in order to assess
the quality of the body of evidence relating to the following out-
comes. We have selected up to a maximum of seven outcomes for
themother and seven for the infant/offspring covering both short-
and long-term outcomes for the main comparisons (high versus
low dose [as defined by authors], defined doses, different infusion
concentrations) and subgroups primiparae and multiparae’.
1. Pain intensity and/or satisfaction with pain relief (as defined
by authors).
2. Breastfeeding exclusive* or full** or partial*** (time points
specified by authors)
3. Method of delivery (unassisted vaginal birth, assisted
vaginal birth, caesarean section)
4. Acidosis in neonate(as defined by cord blood arterial pH
less than 7.15)
5. Admission to special care baby unit/neonatal intensive care
unit (as defined by authors)
6. Poor infant outcomes at long-term follow-up (as defined by
authors e.g. disability, brachial plexus damage, seizures)
We will use the GRADEpro Guideline Development Tool to im-
port data from Review Manager 5.3 (RevMan 2014) in order to
create ’Summary of findings’ tables. A summary of the interven-
tion effect and a measure of quality for each of the above outcomes
will be produced using the GRADE approach. The GRADE ap-
proach uses five considerations (study limitations, consistency of
effect, imprecision, indirectness and publication bias) to assess the
quality of the body of evidence for each outcome. The evidence
can be downgraded from ’high quality’ by one level for serious (or
by two levels for very serious) limitations, depending on assess-
ments for risk of bias, indirectness of evidence, serious inconsis-
tency, imprecision of effect estimates or potential publication bias.
Measures of treatment effect
Our statistician (Alan Watkins (AW)) will identify appropriate
methods for variables to be analysed. Random-effectsmethodswill
be selected, where appropriate.
Dichotomous data
Datawill be dichotomisedwherever possible, using established and
validated criteria, for example, pain scales with gradations of none-
mild-moderate-severe or visual analogue scales with specified cut
points (Moore 2013).
For dichotomous data, we will present results as summary risk
ratio with 95% confidence intervals.
For rare adverse events, including many adverse events, the Peto
odds ratio will be appropriate. Variables where some studies report
zero counts will be considered appropriately, with further checks
on calculations.
Sensitivity analyses will be undertaken dichotomising data to dif-
ferent drug aliquot masses.
Continuous data
For continuous data, we will use the mean difference if outcomes
are measured in the same way between trials. We will use the
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standardised mean difference to combine trials that measure the
same outcome, but use different methods.
We shall follow our statistician’s (AW’s) advice regarding transfor-
mation of skewed data.
Unit of analysis issues
Cluster-randomised trials
We do not anticipate identifying many cluster-randomised trials.
However, we will include cluster-randomised trials in the analyses
along with individually-randomised trials. We will adjust their
sample sizes using themethods described in theHandbook using an
estimate of the intracluster correlation co-efficient (ICC) derived
from the trial (if possible), from a similar trial or from a study of
a similar population. If we use ICCs from other sources, we will
report this and conduct sensitivity analyses to investigate the effect
of variation in the ICC. If we identify both cluster-randomised
trials and individually-randomised trials, we plan to synthesise the
relevant information. We will consider it reasonable to combine
the results from both if there is little heterogeneity between the
study designs and interaction between the effect of intervention
and the choice of randomisation unit is considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a sensitivity analysis to investigate the effects of the
randomisation unit.
Cross-over trials
Not applicable.
Other unit of analysis issues
More than two treatment groups
Where possible, groups will be combined to allow pairwise com-
parisons. This will be facilitated by alignment with definitions of
high and low doses within the trials identified. Data will be ex-
plored using a series of drug mass aliquots as cut points: 50, 100,
150, 200, 300 mcg (Beilin 2005; COMET 2001; Radzyminski
2003). Trial arms will be aligned with drug aliquot cut points, for
example ≤ 50 mcg versus > 50 mcg. The analysis will be repeated
with drug concentrations, and volumes infused.
We shall seek advice on meta-regression for multiple treatment
meta-analysis as a supplementary analysis, if we locate sufficient
data.
Twins and multiple pregnancies
We propose to use the same unit of analysis procedures as the
included trials, and report this. To remove multiple pregnancies
from the data would break the trial’s randomisation. (See Types of
participants, above)
Dealing with missing data
For included studies, wewill note levels of attrition.Wewill explore
the impact of including studies with high levels of missing data
in the overall assessment of treatment effect by using Sensitivity
analysis.
For all outcomes, we will carry out analyses, as far as possible,
on an intention-to-treat basis, i.e. we will attempt to include all
participants randomised to each group in the analyses, and all
participants will be analysed in the group to which they were
allocated, regardless of whether or not they received the allocated
intervention. The denominator for each outcome in each trial
will be the number randomised minus any participants whose
outcomes are known to be missing.
We shall undertake sensitivity analyses excluding participants not
receiving their allocated treatment (per protocol analysis) and ex-
cluding trials where outcomes have more than 20% missing data.
Assessment of heterogeneity
We will assess statistical heterogeneity in each meta-analysis using
the Tau², I² and Chi² statistics. We will regard heterogeneity as
substantial if an I² is greater than 30% and either a Tau² is greater
than zero, or there is a low P value (less than 0.10) in the Chi² test
for heterogeneity.
Assessment of reporting biases
If there are 10 or more studies in the meta-analysis, we will in-
vestigate reporting biases (such as publication bias) using funnel
plots. We will assess funnel plot asymmetry visually. If asymmetry
is suggested by a visual assessment, we will perform exploratory
analyses to investigate it.
Where outcomes are not reported, we shall contact trial authors
to seek missing outcome data.
Data synthesis
We will carry out statistical analysis using the Review Manager
software (RevMan 2014). We will use fixed-effect meta-analysis
for combining datawhere it is reasonable to assume that studies are
estimating the same underlying treatment effect: i.e. where trials
are examining the same intervention, and the trials’ populations
and methods are judged sufficiently similar. If there is clinical het-
erogeneity sufficient to expect that the underlying treatment ef-
fects differ between trials, or if substantial statistical heterogeneity
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is detected, we will use random-effects meta-analysis to produce
an overall summary, if an average treatment effect across trials is
considered clinically meaningful. The random-effects summary
will be treated as the average range of possible treatment effects
and we will discuss the clinical implications of treatment effects
differing between trials. If the average treatment effect is not clin-
ically meaningful, we will not combine trials.
If we use random-effects analyses, the results will be presented as
the average treatment effect with 95% confidence intervals, and
the estimates of Tau² and I².
We shall explore the relationship between opioid doses and con-
centrations and pain scores, using meta-regression, if sufficient
data are available. However, pain scores from different settings
may not be comparable. Therefore, we shall explore the relation-
ship between the differences in change in pain scores, or the pro-
portions with satisfactory pain relief, and the differences in doses
between the trial arms. If we locate sufficient studies, we shall ex-
plore a meta-regression of the differences between doses and pain
relief, both in absolute terms and as ratios. We shall explore pre-
dictor variables, such as trial sample size, any other analgesia co-
administered. We propose to do this as a secondary analysis. We
shall repeat the main analysis including trials where doses of non-
opioid analgesia were not identical across the trial arms. (AW will
guide the analysis.)
We shall justify our decisions on clinical and statistical grounds
(Riley 2011).
Subgroup analysis and investigation of heterogeneity
Heterogeneity may arise from differences in co-administered anal-
gesia in different trials. If we identify substantial heterogeneity, we
will investigate it using subgroup analyses and sensitivity analyses
(listed below). We will consider whether an overall summary is
meaningful, and if it is, use random-effects analysis to produce
it. The number and nature of trials identified will determine the
feasibility of subgroup analyses.
We shall analyse individual drugs separately and together. Doses
and concentrations vary with each drug. All opioids administered
by the epidural route will be analysed separately, and then in com-
bination using recognised dose equivalence charts. Equivalence
data are available for fentanyl, alfentanil, sufentanil, morphine, di-
amorphine and other opioids from manufacturers’ literature and
Internet sources. We shall use the fentanyl: sufentanil potency ra-
tio of 6.3:1, derived in labouring women, as described by Herman
1998 in their study of 100women (whowere not followed through
to the birth and therefore would not meet the criteria for inclusion
in this review).
We thinkwe have identified all relevant subgroups a priori. Post hoc
subgroup analyses will be undertaken, if needed, and interpreted
cautiously.
We plan to carry out the following subgroup analyses if data are
available.
1. Primiparous versus multiparous parturients
2. Term versus preterm birth (as defined by authors)
3. Continuous support in labour versus no continuous support
4. Administration of epidural analgesia containing opioids
before versus after 4 cm dilatation of cervix
5. Spontaneous labour versus induced labour
6. Trials with less than 48 hours versus those with 48 or more
hours follow-up
7. Individual drugs versus all other drugs in combination
8. Resource-poor versus resource-rich settings
9. Trials undertaken before versus after publication of
COMET 2001. Before 2001 versus 2002 and after, excluding
2001 trials
10. Trials administering high (more than 1.25%) versus low
doses (≤ 1.25%) of local anaesthetic epidural infusions
(COMET 2001)
11. Regimens relying on solely bolus versus bolus/infusion
administration, because transfer to the circulation may be more
complete with infusions (Ginosar 2003)
Subgroup analysis will be restricted to the review’s primary out-
comes.
We will assess subgroup differences by interaction tests available
within RevMan (RevMan 2014). We will report the results of
subgroup analyses quoting the Chi² statistic and P value, and the
interaction test I² value.
Sensitivity analysis
Sensitivity analyses will be undertaken:
1. where there is risk of bias associated with the quality of
some of the included trials, in 1 or more of the following criteria
based on ’Assessment of risk of bias’ (Higgins 2011):
i) allocation concealment unclear;
ii) participants unblinded;
iii) outcome assessors unblinded for subjective outcomes,
such as pain or satisfaction;
iv) data analysts unblinded (Personnel are unlikely to be
blinded as to the regimen administered);
v) ≥ 20% missing data;
vi) registered protocol unavailable or mismatch between
outcomes in registered protocol and reports of the trial;
vii) imbalance between trial arms in analgesia before or
after labour.
2. excluding per protocol and ‘as treated’ analyses in turn:
3. to explore the effects of fixed-effect or random-effects
analyses for outcomes with statistical heterogeneity;
4. dichotomising data to different drug mass aliquots;
5. excluding trials wholly or partially funded by
pharmaceutical companies;
6. excluding cluster-randomised controlled trials.
Sensitivity analysis will be restricted to the review’s primary out-
comes.
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A P P E N D I C E S
Appendix 1. Databases search strategy
SEARCH STRATEGIES (Bibliographic Databases)
PubMed (NLM) [1946- ]
Search filter (lines 43 to 52) is adapted from Cochrane Handbook (Higgins 2011) - Cochrane Highly Sensitive Search Strategy for identifying
randomized trials in MEDLINE: sensitivity- and precision-maximizing version (2008 revision); PubMed format.
1. birth[tiab] OR childbirth[tiab]
2. labor[tiab] OR labour[tiab]
3. parturient*[tiab] OR parturition[tiab]
4. intrapartum[tiab]
5. “Delivery, Obstetric”[mesh:noexp]
6. “Labor, Obstetric”[mh]
7. “Labor, Induced”[mh]
8. “Vaginal Birth after Cesarean”[mh]
9. “Labor Pain”[mh]
10. “Parturition”[mh]
11. “Obstetric Labor Complications”[mh]
12. OR /1-11
13. epidural*[tiab] OR neuraxial[tiab]
14. “Anesthesia, Epidural”[mesh:noexp]
15. “Analgesia, Epidural”[mh]
16. OR /13-15
17. alfentanyl OR alfentanil
18. buprenorphine
19. butorphanol
20. diamorphine
21. fentanil OR fentanyl
22. heroin
23. hydromorphone
24. meperidine
25. methadone
26. morphine
27. nalbuphine
28. opiate*
29. opioid OR opioids
30. oxycodone
31. pentazocine
32. pethidine
33. sufentanil OR sulfentanil OR sufentanyl OR sulfentanyl
34. tramadol
35. “Analgesics, Opioid”[mh]
36. OR / 17-35
37. “Dose-Response Relationship, Drug”[mh]
38. “administration and dosage” [Subheading]
39. posolog*[tiab]
40. dose[tiab] OR doses[tiab] OR dosage*[tiab] OR dosing[tiab]
41. ED95[tiab] OR ED50[tiab]
42. OR/ 37-41
43. randomized controlled trial[pt]
44. controlled clinical trial[pt]
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45. randomized[tiab]
46. groups[tiab]
47. clinical trials as topic[mesh:noexp]
48. randomly[tiab]
49. trial[ti]
50. OR / 43-49
51. AND / 12, 16, 36, 42, 50
52. animals[mh] NOT humans[mh]
53. (51 NOT 52)
SCOPUS (Elsevier) [coverage primarily 1960- ]
KEY - searches author keywords, Emtree, Mesh and other index terms included in record
1. KEY(“Delivery,Obstetric”)
2. TITLE-ABS-KEY(labor OR labour)
3. TITLE-ABS-KEY(birth OR childbirth)
4. TITLE-ABS-KEY(parturient* OR parturition)
5. TITLE-ABS-KEY(intrapartum)
6. OR / 1-5
7. TITLE-ABS-KEY(neuraxial)
8. TITLE-ABS-KEY(epidural*)
9. OR / 8-9
10. TITLE-ABS-KEY(nalbuphine)
11. TITLE-ABS-KEY(morphine)
12. TITLE-ABS-KEY(methadone)
13. TITLE-ABS-KEY(meperidine)
14. TITLE-ABS-KEY(hydromorphone)
15. TITLE-ABS-KEY(heroin)
16. TITLE-ABS-KEY(fentan?l)
17. TITLE-ABS-KEY(buprenorphine)
18. TITLE-ABS-KEY(sufentan?l OR sulfentan?l)
19. TITLE-ABS-KEY(opioid*)
20. TITLE-ABS-KEY(diamorphine)
21. TITLE-ABS-KEY(butorphanol)
22. TITLE-ABS-KEY(alfentan?l)
23. TITLE-ABS-KEY(“narcotic analgesic agent*”)
24. TITLE-ABS-KEY(tramadol)
25. TITLE-ABS-KEY(pethidine)
26. TITLE-ABS-KEY(pentazocine)
27. TITLE-ABS-KEY(oxycodone)
28. TITLE-ABS-KEY(opiate*)
29. OR / 10-28
30. TITLE-ABS-KEY(ed95 OR ed50 OR dose OR doses OR dosage* OR dosing OR posolog*)
31. TITLE-ABS-KEY(RANDOM* W/5 STUDY)
32. ABS(groups)
33. TITLE-ABS-KEY(RANDOM* W/5 GROUP*)
34. KEY(“comparative study”)
35. KEY(“controlled study”)
36. KEY(“Prospective Study”)
37. TITLE-ABS-KEY(Random* W/2 assign*)
38. TITLE-ABS-KEY(Random* W/4 allocat*)
39. TITLE-ABS-KEY(Random* W/4 trial*)
40. TITLE-ABS-KEY(clinical PRE/2 trial* OR controlled PRE/2 trial*)
41. TITLE-ABS-KEY(randomi?ation)
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42. TITLE-ABS-KEY(randomly)
43. TITLE-ABS-KEY (“triple blind*” OR tripleblind* OR “treble blind*” OR trebleblind*)
44. TITLE-ABS-KEY (“double blind*” OR doubleblind*)
45. TITLE-ABS-KEY (“single blind*” OR singleblind*)
46. KEY(“random allocation”)
47. TITLE-ABS-KEY(Randomi?ed)
48. KEY(“Controlled trial*”)
49. KEY(“Clinical trial*”)
50. OR/ 31-49
51. AND / 6, 9, 29, 30, 50
Web of Science (Thomson Reuters - ISI)
Science Citation Index Expanded (SCI-EXPANDED) --1970-present
Social Sciences Citation Index (SSCI) --1970-present
Conference Proceedings Citation Index- Science (CPCI-S) --1990-present
TS - searches abstract, title and keywords
1. TS= (alfentan?l OR buprenorphine OR Butorphanol OR diamorphine OR fentan?l)
2. TS= (heroin OR hydromorphone OR meperidine OR methadone OR morphine OR nalbuphine OR opiate* OR opioid* OR
oxycodone)
3. TS= (pentazocine OR pethidine OR sufentan?l OR sulfentan?l OR tramadol)
4. TS=(“narcotic analgesic*”)
5. OR / 1 - 4
6. TS=(birth OR childbirth OR parturient* OR parturition OR intrapartum)
7. TS=((labo$r NEAR/1 pain) OR (labo$r NEAR/1 analgesia) OR (labo$r NEAR/2 an$esthesia) OR (labo$r NEAR/1 onset) OR
(labo$r NEAR/2 stage) OR (obstetric NEAR/1 delivery))
8. OR / 6 - 7
9. TS= (epidural OR neuraxial)
10. TS=(ed95 OR ed50 OR dose OR doses OR dosage* OR dosing OR posolog*)
11. TS= (single-blind* OR double-blind* OR treble-blind* OR triple-blind* OR singleblind* OR doubleblind* OR trebleblind* OR
tripleblind*) OR TS= (random*) OR TS= (controlled NEAR/2 trial*) OR TS= (clinical NEAR/2 trial*) OR TS= (RCT) OR TS=
(“comparative study” OR “major clinical study” OR “multicenter study”) OR TS= (groups)
12. AND / 5,8,9,10,11
MATERNITY & INFANT CARE DATABASE (OvidSP) [ 1971 - ]
.af. = all fields .de. = descriptors .hw.= heading words .ab. = abstract .ti. = title
1. (parturition or parturient$ or birth or childbirth or labor or labour or delivery or intrapartum).af.
2. (epidural or neuraxial).af.
3. (alfentanyl or alfentanil or Buprenorphine or Butorphanol or methadone or tramadol or diamorphine or Fentanyl or fentanil or
heroin or Hydromorphone or meperidine or Morphine or Nalbuphine or opiate$ or opioid$ or oxycodone or Pentazocine or pethidine
or Sulfentanyl or Sufentanyl or sulfentanil or sufentanil).af.
4. Narcotics.de.
5. OR / 3 - 4
6. (dose or doses or dosing or dosage$ or posolog$ or ED95 or ED50).af.
7. AND / 1, 2, 5 , 6
8. Randomised controlled trials.de.
9. Quantitative research.de.
10. (random$ or groups or single-blind$ or double-blind$ or triple-blind$ or treble-blind$ or singleblind$ or doubleblind$ or triple-
blind$ or trebleblind$).af.
11. (trial$ or stud$).ab,hw,ti.
12. OR / 8 - 11
13. AND 7, 12
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CINAHL Plus with Full Text (Ebsco) [1937 - ]
MH = Cinahl Subject Heading. MW= Word in Subject Heading.
Where no fields specified the term(s) are searched in the following fields: Title, Abstract and MW
1. TI birth OR AB birth
2. parturition OR parturient*
3. (MH “Labor+”)
4. TI childbirth OR AB childbirth OR (MH “Childbirth+”)
5. TI(labor OR labour) OR AB(labor OR labour) OR (MH “Labor Complications+”)
6. (MH “Delivery+”)
7. (MH ”Intrapartum Care+“) OR TI intrapartum OR AB intrapartum
8. OR / 1 - 7
9. epidural OR neuraxial
10. (alfentanyl OR alfentanil OR buprenorphine OR butorphanol OR diamorphine OR fentan?l OR heroin OR hydromorphone OR
meperidine OR methadone OR morphine OR nalbuphine OR opiate* OR opioid* OR oxycodone OR pentazocine OR pethidine
OR sufentan?l OR sulfentan?l OR tramadol)
11. (MH ”Analgesics, Opioid+“)
12. OR / 10 - 11
13. dose OR doses OR dosage* OR dosing OR posolog* OR ED95 OR ED50
14. (MH ”Clinical Trials+“)
15. (PT Clinical trial )
16. single blind* or double blind* or treble blind* or triple blind* or singleblind* or doubleblind* or trebleblind* or tripleblind*
17. MH ”Quantitative Studies“
18. MH ”Random Sample“
19. TI randomi?ed or AB randomi?ed
20. TI randomly or AB randomly
21. TI trial* OR (TI study OR AB study)
22. AB groups OR TI groups
23. PT randomized controlled trial
24. OR /14 - 23
25. AND / 24, 13, 12, 9, 8
26. (MH ”Animals+“) NOT (MH ”Humans+“)
27. 25 NOT 26
Appendix 2. Clinical trials search strategy
SEARCH STRATEGIES for Clinical Trials Registers
ClinicalTrials.Gov
((epidural OR neuraxial) AND (labor OR labour OR parturients OR parturition OR birth OR childbirth OR delivery))
ISRCTN Registry
((epidural OR neuraxial) AND (labor OR labour OR parturients OR parturition OR birth OR childbirth OR delivery))
International Federation of Pharmaceutical Manufacturers and Associations [IFPMA]
Epidural [including synonyms] AND labor pain [including synonyms] AND opioids [including synonyms]
WHO International Clinical Trials Registry Platform Search Portal [WHO ICTRP]
Advanced search.
Intervention: epidural OR neuraxial
Condition: labour OR labor OR birth OR childbirth OR delivery
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